Evaluation of early medication persistence with omidenepag isopropyl, a topical selective prostaglandin EP2 agonist, in patients with glaucoma: a retrospective two-institute study

OBJECTIVES: We evaluated early medication persistence with new topical antiglaucoma eyedrops, omidenepag isopropyl 0.002% (a selective prostaglandin EP2 agonist). DESIGN AND SETTING: Retrospective two-institute study in Himeji and Akashi in Japan. PARTICIPANTS: We analysed patients with glaucoma who...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakakura, Shunsuke, Kanamori, Akiyasu, Fukuma, Yasuko, Wakabayashi, Seita, Nagata, Yuki, Adachi, Miku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849894/
https://www.ncbi.nlm.nih.gov/pubmed/33514572
http://dx.doi.org/10.1136/bmjopen-2020-040301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849894/
https://www.ncbi.nlm.nih.gov/pubmed/33514572
http://dx.doi.org/10.1136/bmjopen-2020-040301

Ejemplares similares